Chevron Stock Rises as Adjusted Earnings Top Estimates Barron’sView Full Coverage on Google News Source link
Read More »Tag Archives: Barron039s
Exxon Mobil Stock Rises on Earnings. CEO Cites Highest Upstream Production in 25 Years. – Barron's
Exxon Mobil Stock Rises on Earnings. CEO Cites Highest Upstream Production in 25 Years. Barron’s Exxon earnings beat estimates as production growth softens impact of lower oil prices CNBC ExxonMobil announces second-quarter 2025 results Exxon Mobil Corporation Exxon Chief Says Demand for Oil Remains ‘Very, Very Strong.’ The New York Times Exxon, Chevron profits to drop to lowest point since pandemic, analysts say Yahoo Finance …
Read More »AbbVie Stock Pops After Earnings. What’s Driving Shares Higher. – Barron's
AbbVie Stock Pops After Earnings. What’s Driving Shares Higher. Barron’s AbbVie sees no outsized tariff exposure, boosts profit forecast Yahoo Finance AbbVie in charts: Revenues from Humira -58%, Skyrizi +62%, Rinvoq +42% Y/Y (ABBV:NYSE) Seeking Alpha Is ABBV Stock (ABBV) a Buy Ahead of Q2 Earnings? TipRanks Why AbbVie Stock Slumped Today The Motley Fool Source link
Read More »Cigna Stock Falls on Earnings Even as It Sidesteps the Managed-Care Crisis – Barron's
Cigna Stock Falls on Earnings Even as It Sidesteps the Managed-Care Crisis Barron’s Cigna (CI) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates Yahoo Finance Cigna affirms outlooks as Evernorth Health Services drives growth Modern Healthcare Cigna Profits Hit $1.5 Billion Despite Higher Costs Forbes Wells Fargo surprised to see Cigna stock weaker following pullback TipRanks Source link
Read More »MicroStrategy Beats Earnings Estimates. The Stock Rises. – Barron's
MicroStrategy Beats Earnings Estimates. The Stock Rises. Barron’s Top analyst warns on MicroStrategy results ahead of earnings Yahoo Finance Strategy Announces Second Quarter 2025 Financial Results Strategy MicroStrategy Swings to Profit on Bitcoin Gains The Wall Street Journal MicroStrategy just posted a huge profit. It’s the second time riding on an accounting rule change. MarketWatch Source link
Read More »Trump Talks Tough on Drug Prices but His Demands Have Softened – Barron's
Trump Talks Tough on Drug Prices but His Demands Have Softened Barron’s Trump Demands That Drugmakers Lower Some of Their U.S. Prices by September The New York Times Trump threatens drug giants with crackdown over prices The Guardian Trump calls for price cuts on prescription drugs within 60 days in letters to Eli Lilly, Pfizer, other drugmakers NBC News Trump sends letters to 17 …
Read More »Reddit Stock Jumps 15% as Earnings Beat Estimates and Revenue Soars – Barron's
Reddit Stock Jumps 15% as Earnings Beat Estimates and Revenue Soars Barron’s Reddit shares jump as much as 20% on second-quarter sales and guidance beat CNBC Reddit Stock Surges Higher on Strong Advertising Projections Bloomberg.com Reddit forecasts strong revenue on AI-driven ad strength, shares surge Reuters Reddit set to report Q2 earnings as Wall Street scrutinizes daily active user growth Yahoo Finance Source link
Read More »Why Copper Prices Are Falling After Trump’s 50% Tariff Order – Barron's
Why Copper Prices Are Falling After Trump’s 50% Tariff Order Barron’s Trump slaps universal 50% tariff on copper imports; metal’s price plunges CNBC How Trump’s Copper Tariffs Surprise Shook the Market Bloomberg.com Trump issues blitz of tariff announcements on copper, Brazil, South Korea, small-value imports Reuters ADJUSTING IMPORTS OF COPPER INTO THE UNITED STATES The White House (.gov) Source link
Read More »Meta Stock: Facebook Parent Surges Near Record High. Everything to Know About Its Blowout Earnings. – Barron's
Meta Stock: Facebook Parent Surges Near Record High. Everything to Know About Its Blowout Earnings. Barron’s Meta Shares Soar as Ad Business Continues to Fuel AI Ambitions The Wall Street Journal Meta’s growth strikes Wall Street as incomprehensibly strong, and the stock rockets MarketWatch ‘Superintelligence’ Will Create a New Era of Empowerment, Mark Zuckerberg Says The New York Times Meta Reports Second Quarter 2025 …
Read More »Elli Lilly Weight-Loss Drug Makes Cardio Advance. More Bad News for Novo Nordisk. – Barron's
Elli Lilly Weight-Loss Drug Makes Cardio Advance. More Bad News for Novo Nordisk. Barron’s Lilly’s Mounjaro (tirzepatide), a GIP/GLP-1 dual agonist, demonstrated cardiovascular protection in landmark head-to-head trial, reinforcing its benefit in patients with type 2 diabetes and heart disease Eli Lilly and Company Eli Lilly’s Mounjaro shows heart health benefits in head-to-head trial with older diabetes drug Trulicity CNBC Eli Lilly’s diabetes …
Read More »